Simplify Logo

Full-Time

Executive Director/ Sr. Director of Medical Affairs

Confirmed live in the last 24 hours

Adicet Bio, Inc

Adicet Bio, Inc

51-200 employees

Develops genetically modified T cells for cancer

Biotechnology

Compensation Overview

$297k - $409kAnnually

Senior, Expert

San Carlos, CA, USA

Category
Healthcare Administration & Support
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • MD, PhD, or PharmD. MD/PhD a plus.
  • Broad and deep knowledge of Autoimmune disease and the hematology-oncology landscape.
  • Prior experience working on early-stage and mid-stage oncology programs.
  • Fluency with translational data-rich development programs and ability to engage the medical and scientific community.
Responsibilities
  • Key member of Adicet’s medical team.
  • Leader of Adicet’s medical affairs activities globally; including, but not limited to, organizing, and conducting advisory boards, reaching out to patient advocacy groups, and playing a key role in establishing and maintaining a vibrant network of global experts supporting the development of Adicet’s pipeline.
  • Main point of contact for Investigator Sponsored Trials involving Adicet’s programs.
  • In collaboration with clinical development, co-author and review company-sponsored trial protocols.
  • Coordinate medical communication activities internally and externally.

Adicet Bio, Inc. is a pioneering biotechnology company focused on the development of innovative gamma delta T cell therapies for cancer. This firm's work in advancing genetically modified T cells that selectively target tumors with chimeric antigen receptors and T cell receptor-like antibodies positions it as a leader in oncology treatment advancements. The dedication to enhancing tumor targeting and improving treatment persistence underscores a strong commitment to patient care and scientific excellence, making it a distinguished workplace for professionals passionate about making significant impacts in cancer treatment.

Company Stage

IPO

Total Funding

$243.6M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

1%

2 year growth

42%